---
title: "indications-of-autologous_stem_cell_transplantation"
slug: "indications-of-autologousstemcelltransplantation"
date: "2024-05-09"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ªï¼š[[autologous_stem_cell_transplantation]]

# indications-of-autologous_stem_cell_transplantation

## Multiple myeloma (MM)

Most common indication for ASCT. Generally palliative intent

Up-front consolidation following response to induction chemo or for relapsed/refractory dz (IFM 2009 trial, Blood 2020;136:39; EMN02/HO95 MM trial, Lancet Haematol 2020;7:e456)

## Hodgkin lymphoma (HL)

Chemo-sensitive relapsed dz. Curative intent (Cochrane Database Syst Rev 2013;CD009411)

## DLBCL

Chemo-sensitive relapsed dz. Curative intent (Parma Trial, NEJM 1995;333:1540; CORAL study, JCO 2010;28:4184)

## CNS Lymphoma (DLBCL)

Chemo-sensitive relapsed dz or for up-front consolidation. Curative intent (Blood 2015;125:1403)

## Follicular lymphoma (FL)

Chemo-sensitive early relapsed dz or dz that has progressed to clinically aggressive histology (eg, DLBCL) (JCO 2013;31:1164; LymphoCare Study, BBMT 2018;24:1163)

## Peripheral T-cell lymphoma

Consolidation in first CR or for chemo-sensitive relapsed dz. Curative intent (Blood 2012;30:3093; JCO 2013;31:3100)

## Mantle cell lymphoma

Consolidation in first CR or for chemo-sensitive relapsed dz (BJH 2012;158:355; Blood 2005;105:2677)

## Ig light chain (AL) amyloidosis

Consolidation following initial response to chemo or for relapsed dz. Palliative intent (Blood 2015;126:2345)
